Top of page

IP & Commercial Transactions

Practice

Filters

Legend Biotech $487 million IPO

Davis Polk advised the underwriters in connection with the $487 million SEC-registered initial public offering by Legend…

ADC Therapeutics $267 million IPO

Davis Polk advised ADC Therapeutics SA on its SEC-registered initial public offering of 14,082,475 common shares, which…

SS&C acquisition of Captricity

Davis Polk advised SS&C Technologies Holdings, Inc. on its acquisition of Captricity. Financial terms of the transaction…
Back to top